Connor, Clark & Lunn Investment Management Ltd. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 152 filers reported holding PDL BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$6,828,000
-21.0%
2,167,755
-27.0%
0.04%
-26.2%
Q2 2020$8,646,000
-17.9%
2,970,976
-20.5%
0.06%
-35.1%
Q1 2020$10,535,000
-19.0%
3,735,686
-6.8%
0.09%
+4.4%
Q4 2019$13,004,000
+37.2%
4,007,336
-8.7%
0.09%
+38.5%
Q3 2019$9,476,000
-32.8%
4,387,038
-2.2%
0.06%
-27.8%
Q2 2019$14,091,000
-24.1%
4,487,584
-10.1%
0.09%
-26.2%
Q1 2019$18,568,000
+8.7%
4,991,473
-15.3%
0.12%
+5.2%
Q4 2018$17,083,000
+8.8%
5,890,651
-1.3%
0.12%
+30.3%
Q3 2018$15,696,000
+18.1%
5,968,105
+5.1%
0.09%
+18.7%
Q2 2018$13,286,000
-5.7%
5,677,647
+18.5%
0.08%
-11.8%
Q1 2018$14,082,000
+40.9%
4,789,702
+31.3%
0.08%
+46.6%
Q4 2017$9,992,000
+12.8%
3,646,549
+39.5%
0.06%
+9.4%
Q3 2017$8,862,000
+141.1%
2,614,112
+75.7%
0.05%
+120.8%
Q2 2017$3,675,000
+15.7%
1,487,713
+6.3%
0.02%
+14.3%
Q1 2017$3,176,000
+10.2%
1,398,948
+2.9%
0.02%
+5.0%
Q4 2016$2,881,000
-38.4%
1,358,875
-2.6%
0.02%
-39.4%
Q3 2016$4,674,000
+5.1%
1,395,075
-1.5%
0.03%0.0%
Q2 2016$4,449,000
-5.5%
1,416,875
+0.2%
0.03%
-8.3%
Q1 2016$4,708,000
-4.4%
1,413,675
+1.6%
0.04%
-12.2%
Q4 2015$4,927,000
-9.0%
1,391,675
+29.3%
0.04%
-6.8%
Q3 2015$5,413,000
+380.7%
1,076,150
+514.6%
0.04%
+340.0%
Q2 2015$1,126,000
+11.0%
175,100
+78.1%
0.01%
+42.9%
Q2 2014$1,014,00098,3400.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders